Hi, Continue visiting your profile
user

Login

Email

Password

Create account
Forget password
Reset Password
you forgot your password?

Please enter your email address that you have used during registration:

AnyGenes

INTERFERONS IMMUNE SYSTEM

Interferons immune system plays a vital role in the immune response to viral infections, tumors, and other immune challenges. Interferons (IFNs) are a group of signaling proteins categorized into three main types: Type I (including IFN-alpha and IFN-beta), Type II (IFN-gamma), and Type III (IFN-lambda). Each type has distinct functions and mechanisms of action that are crucial for modulating the immune system.

At AnyGenes, we provide state-of-the-art tools and products designed to aid researchers in studying interferon responses and their associated signaling pathways. Our products help uncover the intricacies of how interferons interact with the immune system, supporting advancements in treatments and diagnostics.

AnyGenes array showcasing interferons and their role in the immune system.

Discover our advanced qPCR arrays for Interferons Immune System research.

Overview of interferon signaling pathways in vertebrate hosts.

Overview of interferon signaling pathways in vertebrate hosts. Production of interferons (IFNs) begins with the binding of viral molecules, such as genomic nucleic acids, to either cell surface or intracellular pattern recognition receptors (PRRs) [18,19]. The resulting signaling cascade activates transcription and secretion of IFNs, which then bind to their associated IFN receptor on the same and nearby cells. Binding of IFNs to their receptors activates a signal cascade by Janus tyrosine kinases (JAK) and tyrosine kinase (TYK) that leads to the phosphorylation of STAT1 and/or STAT2 [9,15]. For type I and III IFNs, STAT1 and STAT2 complex with IRF9 and bind to IFN-stimulated response elements (ISREs) to express IFN-stimulated genes (ISGs). For type II IFNs, phosphorylated STAT1 dimers bind to gamma-activated site (GAS) elements for ISG production [9,15]. In turn, ISGs mediate antiviral effects directly within infected cells, or further induce innate and adaptive immune responses [3,120].

MECHANISMS OF ACTION

Interferons exert their effects by binding to specific receptors on the surface of target cells, activating intracellular signaling pathways that enhance antiviral defenses and promote immune regulation. Upon binding, interferons trigger the expression of various genes involved in immune responses, including.

  • Antiviral Proteins: These proteins inhibit viral replication and enhance the ability of cells to resist infection.
  • Cytokines and Chemokines: Interferons stimulate the production of other cytokines and chemokines that recruit immune cells to the site of infection or inflammation.
  • Major Histocompatibility Complex (MHC) Molecules: IFNs increase the expression of MHC molecules, enhancing the presentation of antigens to T cells and promoting adaptive immune responses

THE ROLE OF INTERFERONS IN THE IMMUNE RESPONSE

Interferons serve multiple functions within the immune system:

  • Antiviral Activity: Type I IFNs activate genes that inhibit viral replication, enhancing the antiviral state of neighboring cells.
  • Immune Modulation: They regulate both innate and adaptive immune responses by influencing the activation of natural killer (NK) cells and T lymphocytes.
  • Inflammation Control: While promoting an immune response, interferons also help to mitigate excessive inflammation that can lead to tissue damage.

INTERFERONS IN CANCER THERAPY

In addition to their antiviral properties, interferons are increasingly recognized for their role in cancer immunotherapy. Type I interferons, particularly IFN-alpha, have been used to treat certain cancers, such as melanoma and chronic myeloid leukemia, by enhancing the immune response against tumor cells. They help to stimulate T cell activity and promote the expression of tumor-associated antigens, making cancer cells more visible to the immune system.

THERAPEUTICS APPLICATIONS

Interferons are used clinically for various conditions, including:

  • Viral Infections: Such as hepatitis B and C.
  • Autoimmune Diseases: Interferon-beta is used in treating multiple sclerosis by modulating the immune response.
  • Cancer: Interferon therapies are employed to enhance anti-tumor immunity.
(1) He Y, et al. Suppression of Interferon Response and Antiviral Strategies of Bunyaviruses. Trop Med Infect Dis. (2024)7;9(9):205.
(2) Liu YG, et al. Interferon lambda in respiratory viral infection: immunomodulatory functions and antiviral effects in epithelium. Front Immunol. (2024)1:15:1338096.
(3) Schoggins JW. Interferon-Stimulated Genes: What Do They All Do? Annu Rev Virol. (2019)29;6(1):567-584.
(4) Lee AJ, Ashkar AA. The Dual Nature of Type I and Type II Interferons. Front Immunol. (2018)11;9:2061.
(5) MacMicking JD. Interferon-inducible effector mechanisms in cell-autonomous immunity. Nat Rev Immunol. (2012)25;12(5):367-82.

INTERFERONS IMMUNE SYSTEM BIOMARKER LIST

Customize your own signaling pathways (SignArrays®) with the factors of your choice!
Simply download and complete our Personalized SignArrays® information file and send it at contact@anygenes.com to get started on your project.

You can check the biomarker list included in this pathway, see below:
Quitter la version mobile